AGP Picks
View all

US Culture & Style Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Culture & Style Today.

Press releases published on September 2, 2026

Ascentage Pharma to Participate in Four Upcoming Investor Conferences
BioAge Labs to Present at Upcoming Investor Conferences
Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Disc Medicine to Participate in Upcoming Investor Conferences
Annexon to Participate in Upcoming September Investor Conferences
Geron to Present at Upcoming Investor Conferences
Alpha Tau to Participate in September Investor Conferences
Zevra Therapeutics to Present at Upcoming Investor Conferences
Rezolute to Participate in Upcoming Investor Conferences
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Dyne Therapeutics to Participate in Upcoming Investor Conferences
FuelCell Energy Reports Third Fiscal Quarter 2026 Results; Executes First Data Center Power Agreement, Increases Annualized Production Rate & Focuses on Capacity Expansion
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
Cardiff Oncology to Participate in September 2026 Conferences
FactSet Schedules Fourth Quarter 2026 Earnings Call
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
Maze Therapeutics to Participate in Three Upcoming Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

US Culture & Style Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.